Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
In this study, we aimed to investigate the involvement of two anti-inflammatory proteins, progranulin (PGRN) and secretory leukocyte protease inhibitor (SLPI), in the regulation of cervical ripening and to gain new insights for the treatment of preterm birth. Analysis of mouse models of preterm birth and clinical specimens revealed that PGRN and SLPI were produced abundantly at the cervix and fetal membrane. Expression patterns at the cervix were different between PGRN and SLPI depending on the causes of preterm birth. Anti-inflammatory and anti-protease properties are shared among PGRN and SLPI, but they might play distinct roles in the regulation of cervical ripening.
|